ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in ImageneBio, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −3 vs. Q2 2021
- Shares held
- 20.9M
- −184.9K (−0.9%) vs. Q2 2021
- Total value
- $271.8M
- −$21.4M (−7.3%) vs. Q2 2021
- New holders
- 2
- 20 more added
- Sold out
- 5
- 8 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Captrust Financial Advisors | 113 | $1.00K | 0.00% | +113 | New |
| UBS Group AG | 85 | $1.00K | 0.00% | +85 | New |
| Tower Research Capital LLC (TRC) | 746 | $9.00K | 0.00% | −482−39.3% | Reduced |
| Ameritas Investment Partners, Inc. | 711 | $9.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 932 | $12.0K | 0.00% | +209+28.9% | Added |
| Citigroup Inc | 1,365 | $17.0K | 0.00% | +935+217.4% | Added |
| Royal Bank of Canada | 1,495 | $19.0K | 0.00% | +874+140.7% | Added |
| STRS Ohio | 2,100 | $26.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 3,231 | $41.0K | 0.00% | +2,867+787.6% | Added |
| JPMorgan Chase & Co | 3,980 | $50.0K | 0.00% | +499+14.3% | Added |
| California State Teachers Retirement System | 4,846 | $61.0K | 0.00% | −7,677−61.3% | Reduced |
| American International Group, Inc. | 5,687 | $72.0K | 0.00% | +606+11.9% | Added |
| Deutsche Bank AG | 5,974 | $75.0K | 0.00% | +590+11.0% | Added |
| New York State Common Retirement Fund | 7,789 | $98.0K | 0.00% | +89+1.2% | Added |
| Bank of America Corp | 10,922 | $138.0K | 0.00% | +6,624+154.1% | Added |
| Wells Fargo & Company | 14,222 | $180.0K | 0.00% | +10,015+238.1% | Added |
| Bank of New York Mellon Corp | 22,874 | $288.0K | 0.00% | +4,801+26.6% | Added |
| Charles Schwab Investment Management Inc | 25,304 | $320.0K | 0.00% | +2,535+11.1% | Added |
| Nuveen Asset Management, LLC | 33,084 | $429.0K | 0.00% | +6,029+22.3% | Added |
| Victory Capital Management Inc | 91,540 | $1.16M | 0.00% | −640−0.7% | Reduced |
| Northern Trust Corp | 91,757 | $1.16M | 0.00% | +6,695+7.9% | Added |
| Ensign Peak Advisors, Inc | 100,000 | $1.26M | 0.00% | 00.0% | Unchanged |
| State Street Corp | 132,468 | $1.67M | 0.00% | +56,016+73.3% | Added |
| Geode Capital Management, LLC | 194,461 | $2.45M | 0.00% | +77,211+65.9% | Added |
| Credit Suisse AG | 199,781 | $2.52M | 0.00% | −102,838−34.0% | Reduced |
| Octagon Capital Advisors LP | 275,000 | $3.47M | 0.85% | −125,000−31.3% | Reduced |
| Logos Global Management LP | 299,853 | $3.78M | 0.27% | 00.0% | Unchanged |
| CHI Advisors LLC | 315,000 | $3.98M | 1.16% | −499,756−61.3% | Reduced |
| HealthCor Management, L.P. | 339,951 | $4.29M | 0.19% | −37,600−10.0% | Reduced |
| BlackRock Inc. | 483,931 | $6.11M | 0.00% | +34,193+7.6% | Added |
| Vanguard Group Inc | 620,686 | $7.83M | 0.00% | +292,074+88.9% | Added |
| Ra Capital Management, L.P. | 750,000 | $9.46M | 0.13% | 00.0% | Unchanged |
| Artal Group S.A. | 1,549,513 | $19.6M | 0.48% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 1,117,349 | $22.4M | 0.12% | 00.0% | Unchanged |
| BVF Inc | 1,832,071 | $23.1M | 0.90% | +64,672+3.7% | Added |
| Citadel Advisors LLC | 2,127,085 | $26.8M | 0.03% | −29,536−1.4% | Reduced |
| Omega Fund Management, LLC | 2,249,123 | $28.4M | 3.18% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 2,933,941 | $37.0M | 0.41% | 00.0% | Unchanged |
| FMR LLC | 5,031,140 | $63.5M | 0.01% | +599,483+13.5% | Added |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −349,660−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −61,561−100.0% | Sold out |
| Pinz Capital Management, LP | 0 | $0 | 0.00% | −25,390−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −11,984−100.0% | Sold out |